Carbidopa and levodopa and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Carbidopa and levodopa and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and Levodopa
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and levodopa-Insulin degludec
- Carbidopa and levodopa-Insulin Degludec (U-100) Prefilled Pens
- Carbidopa and levodopa-Insulin Degludec (U-100) Vials
- Carbidopa and levodopa-Insulin Degludec (U-200) Prefilled Pens
- Carbidopa and levodopa-Insulin degludec and liraglutide
- Carbidopa and levodopa-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Carbidopa and levodopa enteral
- Insulin aspart, recombinant Subcutaneous-Carbidopa and Levodopa Enteral Suspension
- Insulin aspart, recombinant Subcutaneous-Carbidopa and Levodopa Extended-Release Capsules
- Insulin aspart, recombinant Subcutaneous-Carbidopa and Levodopa Extended-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Carbidopa and Levodopa ODT
- Insulin aspart, recombinant Subcutaneous-Carbidopa and Levodopa Orally Disintegrating Tablets